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ABSTRACT OF DISSERTATION

DEVELOPMENT OF A PATIENT SPECIFIC IMAGE PLANNING SYSTEM FOR
RADIATION THERAPY
A patient specific image planning system (IPS) was developed that can be used
to assist in kV imaging technique selection during localization for radiotherapy.
The IPS algorithm performs a divergent ray-trace through a three dimensional
computed tomography (CT) data set. Energy-specific attenuation through each
voxel of the CT data set is calculated and imaging detector response is
integrated into the algorithm to determine the absolute values of pixel intensity
and image contrast. Phantom testing demonstrated that image contrast resulting
from under exposure, over exposure as well as a contrast plateau can be
predicted by use of a prospective image planning algorithm. Phantom data
suggest the potential for reducing imaging dose by selecting a high kVp without
loss of image contrast. In the clinic, image acquisition parameters can be
predicted using the IPS that reduce patient dose without loss of useful image
contrast.
KEYWORDS: image planning system, radiotherapy, image-guided therapy,
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CHAPTER 1: INTRODUCTION

1.1

Objective of the Thesis
It has long been held in the practice of radiation therapy (RT) that imaging

doses are reliably inconsequential in comparison to therapeutic doses. This
assumption can no longer escape scrutiny. Conventionally, this may have been
true when megavoltage (MV) portal images were acquired weekly. Even as
planar kilovoltage (kV) imaging systems were integrated into the localization
process, the daily doses typically received by these techniques were small.
However, the application of increasingly precise methods of RT delivery has
prompted the need for more aggressive use of image-guided patient position
verification.
Concerns over imaging dose in RT prompted the formation of Task Group
(TG) 75 of the American Association of Physicists in Medicine (AAPM).1 In their
report, they cite that the imaging dose can exceed the limit for background dose
from head leakage and can increase the therapeutic dose by several percent.
The report states that typical doses delivered by planar kV, fluoroscopy and realtime stereotactic radio-surgery (SRS) systems can be 3, 100 and 200 milli-gray
(mGy), respectively. They add that "planar kV imaging presents the possibility of
deterministic skin injury."
When considered in the context of normal tissue sparing, imaging doses
can represent an even higher fractional increase in the delivered dose. For
1

example, an adjacent normal tissue could reasonably be expected to receive on
the order of 1000 mGy from scatter and leakage from an RT treatment. The
addition of several hundred mGy thus represents a 10 - 50 % increase in dose.
The clinical impact of this is uncertain, and may represent a reasonable cost
associated with superior patient positioning. In contrast, it may be considered an
unacceptable risk that should be reduced to the degree practical. Therefore, the
amount of imaging dose that RT patients receive is of concern. Regardless, the
science and practice of RT will benefit from an accurate knowledge of the
imaging dose received by patients.
RT delivery is relying more heavily on image guidance. Absent the ability
to predict image quality and patient dose, image acquisition parameters are
established via generalization, subjective estimation and trial and error.
Optimally, images will be acquired using acquisition parameters that produce the
least patient dose that will achieve the imaging goal. It is improbable that current
practice results in this situation. The geometric precision with which RT is
delivered has improved markedly over the past 10 years. Intensity modulated
radiation therapy (IMRT) and stereotactic body radiotherapy (SBRT) require that
target positioning be achieved with millimeter accuracy. Patient immobilization
systems are imperfect in their ability to assure reproducibility and are unable to
fully eliminate intra-fraction patient motion. These concerns present an
imperative for aggressive image-guidance.
In many clinical scenarios, it is desirable for imaging to be performed in
real time, and extend for the duration of the radiation delivery. Currently, this
2

practice is limited to SRS systems. However, it is likely that if imaging goals were
overtly prescribed, and if the resulting patient dose were well understood, that
this practice could be extended to other clinical scenarios. The lack of this
information is likely limiting the use of real-time image guidance. Increased use of
real-time image guidance could help alleviate concerns over discrete patient
movements, as well as allow for assessment of respiratory motion. In fact,
respiratory-gated and motion tracking technologies would benefit from removing
their reliance on motion surrogates, such as reflective markers, that have been
shown to have limited correlation with tumor motion.2,3
The study of organ specific response to radiation doses produced by
medical imaging suffers from limited precision. Current algorithms for assessing
organ dose rely on generalized data collected from large patient populations. The
dose variation across individual organs can be an order of magnitude, depending
on dimensions, density and the spectral quality of the imaging beam. In current
practice, the addition of imaging and therapy doses in a meaningful way is
elusive. As indicated in TG 75, the regional doses delivered in RT are, by design,
highly variable. Whereas in imaging applications, the doses are regionally
uniform, with the exception of the indeterminate dose gradients produced by
planar imaging techniques. TG75 recommends that "imaging dose should be
managed on a case-by-case basis," despite the fact that there is no current
precedent nor are there accurate and efficient tools with which to do so. We
believe that our project takes advantage of a unique opportunity.

3

The patient-specific image planning system (IPS) for radiotherapy that we
developed in this research work will allow RT clinicians to efficiently simulate the
characteristics of planar kV x-ray images using patient-specific computed
tomography (CT) scans (acquired during routine simulation). These planar
images are used for patient alignment before treatment during radiotherapy.
Imaging dose in terms of entrance skin exposure (ESE) will be calculated for
each set of image acquisition parameters and compared to acceptable levels. By
routinely calculating and reporting the dose statistics for specific organs, a large
data resource will emerge. Our understanding of radiation induced comorbidities, as well as stochastic and deterministic effects may evolve as a result
of the increased data precision.
Our IPS is capable of predetermining optimal image acquisition
parameters (such as kV and mAs) for a given level of patient dose and imaging
goals that are valuable and achievable. For example, for scenarios in which the
soft tissue tumor volume is potentially visible, as is often the case for lung
tumors, imaging parameters and dose may be increased to the point of achieving
minimum reliable detectability. In contrast, if low contrast object detectability is
virtually impossible using reasonable imaging doses, then regional high contrast
objects must be targeted for imaging with imaging doses reduced appropriately
to achieve minimum reliable detectability. We expect that this will result in a
paradigm shift in image-guided radiation therapy (IGRT) planning, in that the
imaging goal will be overtly determined prospectively, the associated dose will be

4

determined prior to imaging on a patient-specific basis, and the imaging dose will
always be the minimum required in order to achieve the imaging goal.
For any given patient, the outcome of the use of the IPS falls under one of the
following three categories.
The imaging dose will be reduced relative to what it would have been
without the use of the system, with no loss in useful image quality.
The imaging dose may be increased to well-defined, patient-specific
predetermined levels, with an ensuing increase in useful image quality
Real-time image guidance will be applied quantitatively, using image
acquisition techniques and exposure thresholds that are prescribed and
well-defined.

1.2

Radiation Therapy
RT is the use of ionizing radiation to kill cancer cells in the human body.

Cell death is the result of damage to cellular DNA. The goal of RT is to kill all of
the cancer cells and to spare as much surrounding normal tissue cells as
possible. There are three approaches to RT:
(1) External beam radiation: In external beam methods, the radiation beams
generated outside of the patient by a linear accelerator (Linac) are
focused at the tumor site.

5

(2) Brachytherapy: In brachytherapy, a radiation source encapsulated and
sealed within a thin metallic sheath is placed inside the body close to
tumor site to deliver radiation internally.
(3) Nuclear medicine: In nuclear medicine, an unsealed radiation source
attached to a radiopharmaceutical or antibody is injected or taken orally to
deliver radiation internally.
Among these three approaches, external beam radiation is the most
common form of RT for many treatment sites. It is non-invasive and allows for
sparing of normal healthy tissues and dose escalation.4 Three-dimensional
conformal radiation therapy (3-D CRT) is used to meet the goal of RT. It is
feasible only with a three-dimensional (3-D) view of the patient anatomy and a 3D visualization of the dose distribution in the tumor and adjacent organs at risk
(OARs). Figure 1.1 summarizes the basic steps of 3-DCRT.

CT
CTData
DataAcquisition
Acquisition

Virtual
Virtual Simulation/
Simulation/
Treatment
Treatment Planning
Planning

Quality Assurance

Treatment Delivery

Figure 1.1: Block diagram shows basic steps of 3-D CRT.
6

CT was developed in the 1970s, and allowed reconstruction of the
patient‘s anatomy in 3-D. This improved the diagnostic accuracy with which
physicians could determine the location and extent of disease. However, it was
not until the mid-1990s that CT ‗simulation‘ software was developed
commercially and rendered 3-DCRT delivery possible in the clinic. Two major
components of a CT simulator are the CT scanner and the virtual simulation
software.5 Simulation in RT refers to a process that defines the parameters of the
patient set up and treatment geometry. In the initial phase of CT simulation,
patient-specific immobilization and custom treatment devices are constructed if
required. The patient is aligned on the CT simulator table in the treatment
position with a three point setup technique using room lasers. Radio-opaque
fiducial materials are placed on those anterior and lateral positions of the patient
as external markers. The patient is then tattooed with few permanent ‗pin‘ dots to
record the position of those external markers. This allows for reproducible patient
setup on the Linac prior to daily treatment. The patient is then scanned on the
CT.
The patient‘s CT data are transferred to a powerful computer graphics
workstation called a virtual simulator (VS). Virtual simulation is now built into the
treatment planning system (TPS) itself. Treatment simulation of patient is carried
out solely on the 3-D patient model that is created from the CT volume data of
the patient. The tumor volume and organs at risk are defined directly on the CT
images by a physician. The physician also places the isocenter, or focal point of
the radiation beams. Radiation beam directions and radiation field shapes are
7

optimized by using a Beam‘s eye view (BEV) display. Dose calculation and final
treatment plan optimization are then performed. 6 An optimized and approved
treatment plan is exported to the Linac control computer. Quality assurance (QA)
of clinical treatment planning and of all equipment that are used in the course of
radiation delivery is performed to ensure that the tumor is irradiated by the
appropriate medical prescription dose together with minimal dose to surrounding
normal tissues.7,8 Treatment is delivered to the patient after verifying that the
patient is positioned correctly on the Linac and the beam parameters are
accurately and reproducibly set. Patient positioning accuracy of ± 1-2 millimeter
(mm) can be achieved for an IMRT Linac.

1.3

Digitally Reconstructed Radiograph
A digitally reconstructed radiograph (DRR) is a fixed image of a particular

beam orientation and a critical element in the process of virtual simulation. The
DRR is used for patient alignment before delivering the treatment by comparing it
with the image acquired by an imaging system attached to Linac.
DRRs are computer generated planar x-ray like images produced by
tracing divergent ray lines from a virtual source position to a virtual plane,
through the 3D patient model containing attenuation coefficient information in the
form of CT numbers.9,10 Figure 1.2 is a schematic diagram of the spatial
distribution of the transmitted intensity that impinges on the imaging plane.
8

Figure 1.2: Schematic diagram of ray tracing from a virtual source position
through an arbitrary patient model on the imaging plane. The sum of the
attenuation coefficients along all ray lines at different positions on the imaging
plane produces the spatial distribution of intensity on the imaging plane.
Figure 1.3 is a DRR of a pelvic region generated from a 3-D CT data set.
The DRR was produced by a commercial TPS. A DRR serves as the reference
image in evaluating the daily position of the patient. The radiation isocenter is
9

indicated by the plus sign, and provides an absolute reference point for spatial
alignment.

Figure 1.3: A DRR of a pelvis is shown. The DRR was generated by a
commercial treatment planning system. The multi-leaf collimator (MLC) field
shape and the isocenter are shown in the DRR image. Blue lines show how
MLCs conform to target volume. Variations in net transmitted intensity reveal
anatomical information, especially that pertaining to boney anatomy. Courtesy of
M. Y. Y Law.11

1.4

Image Guided Radiation Therapy
A critical step for conformal RT is accurate patient setup and target

localization in the treatment position. IGRT refers to imaging performed in the
treatment room immediately prior to, or during RT treatment. IGRT is an
10

approach for conformal radiation delivery as traditional methods like skin marks
or tattoos and boney structures from port films are not very reliable for patient
alignment. Because of an organ motion and changes in its anatomic shape and
size during the course of the treatment, skin marks and tattoos may be
problematic for patient alignment. Port films are taken at MV beam qualities, and
as such there is no soft tissue contrast and even boney detail is poor, and hence
may be problematic for patient alignment.
Various types of digital imaging technologies are used for IGRT with
imaging devices mounted to the treatment machine or in the treatment room.
With IGRT technology, the dose can be delivered precisely to the tumors by
monitoring tumor motion.12 The radiation beam can then be adjusted based on
the position of the target and critical organs while the patient is in the treatment
position.
Among different techniques of IGRT, a kV imaging device referred to as
an on- board imager (OBI) (OBI, Varian Medical Systems, Palo Alto, CA) has
been in routine clinical use in our clinic. This research work is limited only in
radiographic mode of the OBI system. In the OBI system, radiographic images
(referred to herein as ―OBI images‖) mainly reveal boney anatomy, since soft
tissue is almost always indistinguishable in these images. By means of
specialized computer software, these images are compared to the images taken
during simulation. Necessary adjustments are then made to the patient‘s position
for more precise targeting of the radiation beams.
11

1.5

Equipment Used in Research Work
A Varian 21 Platinum (Varian Medical Systems, Palo Alto, CA) Linac in

our clinic is equipped with a kV OBI system in addition to the MV electronic portal
imaging device (EPID) and is shown in Figure 1.4. OBI is one of the IGRT tools
in routine clinical use for RT delivery. It is a device mounted perpendicular to the
treatment beam on the Linac. The OBI consists of a kV x-ray source (kVS) and a
kV amorphous silicon detector (kVD) mounted on two robotic arms called
ExactArms®. These arms can be moved along three axes of motion (i.e. laterally,

Figure 1.4: The Linac and OBI system used at University of Kentucky Radiation
Medicine clinic is shown. The kVS is on the left in the figure and the kVD is
opposite to it.
longitudinally and vertically). The source to detector distance is variable, but is
most often set to 150 cm. The source to axis distance is 100 cm. Verification of
patient position on the treatment table can be accomplished with three kV-

12

imaging

modes:

radiographic,

fluoroscopic

and

cone-beam

computed

tomography (CBCT). All studies presented herein pertain to radiographic mode.

1.5.1 Kilovoltage source
The x-ray source is a Varian G242 model. It is a rotating anode x-ray tube
with a tungsten/ rhenium (W-Re) target that has an inherent filtration of 0.7 mm
plus an additional 2.0 mm aluminum filtration. The tube has a target angle of 14°,
focal spot sizes of 0.4 and 0.8 mm, anode diameter of 100 mm, anode heat
capacity of 600 kilo-heat units (kHU) and a maximum field size of 50×50 cm2 at
the isocenter. The source, like most imaging systems, has variable tube voltage,
tube current and time settings that can be manually selected by the user. It
generates photon spectra with kVp values ranging between 40 and 150 kVp in
radiographic mode. It is driven by a 32 kW x-ray generator. X-ray beam
collimation is produced by an assembly of a fixed primary beam aperture and an
adjustable blade collimation system. Symmetric and asymmetric fields can be
produced by the blade collimation system with a minimum and maximum field
size of 2.5×2.5 cm2 and 50×50 cm2 at the isocenter.13

1.5.2 Flat panel detector
A FPD provides a high spatial resolution (pixel size, 100-200 µm), fast
readout (0.4 s-1.5 s) and a wide dynamic range (70-100 dB).14
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There are two

types of FPDs in use. The indirect type involves a two-step process, in which x13

ray energy is first transformed into visible light using an x-ray scintillator material
and then the light photons are converted into proportional charge by an array of
millions of pixel sized photodiodes (Figure 1.5).

Figure 1.5: Block diagram showing the principle of indirect type digital FPD. In
the first step, x-rays are converted into light photons by the scintillator phosphor
material. In the second step, photodiode/transistor arrays convert light photons
into electrons.
In the direct type FPD, x-rays are directly converted into charge using a
semiconductor material such as amorphous selenium.17 Because of elimination
of the intermediate scintillator layer, direct type FPD exhibit higher spatial
resolution compared to indirect type FPD. Both indirect and direct FPDs share
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the same type of readout mechanism. The working principle of the Varian OBI
system uses an indirect type FPD, and is described in Chapter 2.

1.6

Patient Alignment Using OBI System in Radiographic Mode
A pair of orthogonal images is taken with the patient in treatment position.

These images can be acquired at vendor-provided preset technique factors
depending on the anatomical site and general size of the patient. Images can
also be acquired by setting the technique factors manually. These orthogonal
images are then compared to the corresponding orthogonal DRRs of the same
views using the 2D2D matching software on the OBI workstation. Here, the user
has the ability to compare the images using a variety of software tools including
inversion effects and roving regions of interest (ROIs). The images can then be
manually or automatically matched, and a suggested shift in x-, y- and zcoordinates is displayed. If this shift is accepted, the coordinates are sent to the
Linac controller computer and the couch is automatically shifted prior to
treatment.

1.7

Computed Tomography
CT imaging can be divided into a four step process: data acquisition,

preprocessing of raw data, image reconstruction and image display. During data
acquisition, the x-ray tube (and the x-ray detectors situated opposite to the x-ray
15

tube) rotates around the patient, who is positioned in the gantry aperture. As the
radiation passes through the patient, it is attenuated by the various organs and
tissues that lie in its path. The x-ray beam intensity is attenuated exponentially
according to the Lambert-Beer law:18
(1.1)
where It is the transmitted beam intensity after the beam has passed through a
thickness t of a patient, I0 is the initial beam intensity incident on the patient and
µ is the average linear attenuation coefficient along the ray. Equation (1.1) yields:
(1.2)
Since the ray traverses through voxels of different radiological path lengths,
composition and density, the single measurement of

can be broken up into a

series of measurements.
(1.3)
where

corresponds to attenuation coefficient of ith voxel that has radiological

path length,

(i.e., product of electron density and path length corresponding to

the voxel).
After preprocessing of the raw data, image reconstruction is performed
using different mathematical reconstruction algorithms (e.g. filtered back
projection algorithm) to convert these transmission measurements or projections
into a spatial distribution of the x-ray attenuation coefficients. These values are
then mapped to each voxel of the tissue into different shades of gray. Each
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attenuation coefficient will be assigned a CT number (measured in Hounsfield
units, HU) and hence the CT image displays CT numbers: 19
(1.4)
where µtissue and µwater correspond to the attenuation coefficient of the tissue and
water respectively. The scanner is usually calibrated to result in a µwater = 0 HU
and µair = -1000 HU. The resulting image is typically a 512 x 512 matrix, or
262,144 ―pixels‖ with 12 bits of gray scale, for a total of 4,096 shades of gray.
This means that the signal in each pixel of CT image will have one of the values
of HU from -1000 to + 3095.
However, human eyes cannot resolve that many shades of gray in the
image but can only discern 30 to 90 shades of gray. We can change the
appearance of the image by varying the window width (WW) and window level
(WL). This post-processing procedure spreads a small range of CT numbers over
a large range of grayscale values. This makes it easy to detect very small
changes in CT number. Choice of WW and WL depends on clinical need and is
user-selectable. There are also settings in which the CT image can be displayed
with user definable brightness and contrast values.
In this investigation, a GE Lightspeed RT Xtra CT (GE Health, Waukesha,
WI), shown in Figure 1.6 was used. It has an 80 cm wide bore and contains 16
slices. The x-ray generator kV range is from 80-140 kVp and slice thickness
ranges from 0.625 to 10 mm.
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Figure 1.6: GE Lightspeed RT Xtra CT at University of Kentucky radiation
medicine clinic. It was used to acquire CT images of the phantoms and the
patients used in our study.
In spiral or helical CT, rotation of the x-ray source-detector assembly and
table translation occur simultaneously throughout data acquisition. As such, the
x-ray focus describes a helical path around the patient. A multislice helical CT
scanner is equipped with a multiple-row detector array and collects data
simultaneously at different slice locations. This results in faster imaging,
improved longitudinal spatial resolution and better utilization of x-ray power. 20
Slices of different widths can be acquired by changing the beam collimation and
electronically binning several detector rows together. Image quality is high and
artifacts are reduced with multislice helical CT scanning.21
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1.8

Structure of the Thesis
In this thesis, I discuss the development of a patient-specific image

planning system that is capable of predetermining the optimal acquisition
parameters using a common radiotherapy planar imaging chain. The IPS can be
used to assist in imaging technique selection during localization for radiotherapy
for a given level of patient dose and imaging goal.
The thesis consists of five chapters:
 A brief introduction to concepts relevant to issues discussed in this thesis
such as DRRs, IGRT modalities, CT and our motivation for development
of the IPS is given in Chapter 1.
 Chapter 2 describes the theoretical background of the types of interaction
mechanisms of radiation with matter, risk benefit analysis of X- ray
imaging and calculation of patient specific metrics like imaging dose
resulting from different kV imaging parameters.
 The concise description of the development of an algorithm that simulates
a range of image acquisition parameters and predicts the resulting image
characteristics is presented in Chapter 3 along with data acquired using
several test phantoms. The phantoms include a Respiratory Motion
Phantom, a Mammography Step Wedge Phantom, and two Abdominal
Phantoms. IPS predictive capability of small changes in contrast, image
quality plateau, under and over exposure effects are established.
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 Chapter 4 includes data measured with an anthropomorphic phantom
which simulates human anatomy, for further justification of the IPS
capability of predicting image contrast, under and over exposure effects
and image quality plateau. Clinical data that show IPS capability of
reducing patient imaging dose is also included.
 Chapter 5 presents the conclusions that can be drawn from chapters 3
and 4.

Copyright © Bishnu Bahadur Thapa, 2013
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CHAPTER 2: THEORETICAL BACKGROUND

2.1

Interaction of Radiation in Matter
As photons are transmitted inside the body, their differential attenuation is

responsible for creating the subject contrast that is encoded in the x-ray pattern
that emerges from the patient. When the x-ray pattern interacts with a detector
material, the subject contrast is transformed into visible image contrast, creating
a two-dimensional image that can be displayed and viewed.
Photons are an indirectly ionizing radiation. They undergo a transformative
event when interacting with matter that leads to a significant energy transfer to
electrons. This transfer imparts energy to matter, where radiation dose is
deposited.
Photoelectric absorption, Rayleigh scattering, Compton scattering and pair
production are the four major types of radiation interactions with matter. The
relative importance of each of these interactions depends on the incident photon
energy and the atomic number of the absorbing medium. While photoelectric
absorption, Rayleigh scattering and Compton scattering play a major role in
diagnostic radiology,22 photoelectric absorption, Compton scattering and pair
production play a major role in RT. Photonuclear and other interactions have low
probability in the therapeutic energy ranges in biological matter, and do not play
a significant role.
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2.1.1 Photoelectric absorption
In a photoelectric interaction, the incident photon interacts with tightly
bound, lower shell electron (usually the K shell) of an atom. The photon is
completely absorbed and an electron, the photoelectron, is emitted with kinetic
energy (

(

) equal to the photon energy (

) minus the orbital binding energy

) assuming that kinetic energy imparted to the recoiling atom is nearly zero.
(2.1)
This scattered electron can produce further electron-electron ionization

events, producing a large number of secondary electrons along its trail. These
secondary electrons then deposit the dose locally producing biological damage.
Photoelectric interaction is followed by a subsequent cascade of electron
transitions from a higher-energy orbital to fill the vacated lower-energy orbital.
This results in the emission of characteristic radiation as shown in Figure 2.1, so
called because its energy is characteristic of the atom‘s Z-value. Except in
mammography, characteristic x-rays have no constructive role for x-ray imaging.
In low Z materials like soft tissue of the human body, another competiting
process called Auger electron emission predominates in carrying away the
atomic excitation energy. In Auger electron emission, energy released because
of electron transition is transferred to an orbital electron, typically in the same
shell as the cascading electron.
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Figure 2.1: In a photoelectric absorption event, an incident x-ray photon collides
with a low energy (in this case, K-shell) orbital electron and transfers all of its
energy to the electron. The photoelectric event is followed by a subsequent
cascade of transitions of electrons from a higher-energy orbital to fill the vacated
lower-energy orbital. This results in emission of a characteristic radiation or an
Auger electron.
Photoelectric effect is a first order perturbation theory calculation in which
transition takes place in between an initial state (consisting of a bound electron
wave function and an incident photon wave function) and a final state (consisting
of a free electron wave function). The exact solutions to the equations are difficult
and tedious, since the Dirac relativistic equation for a bound electron has to be
used.23 Discussion on this topic is beyond the scope of this dissertation.
However, photoelectric interaction cross section per atom is found to be
proportional to:
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(2.2)

n ~ 4 at

= 0.1 MeV and gradually rises to ~ 4.6 at 3 MeV.

m ~ 4 at

= 0.1 MeV and gradually rises to ~ 1 at 5 MeV.24

Photoelectric interaction cross section depends on photon energy. In the
keV energy range (i.e. ≤ 100 keV) where the photoelectric interaction is the most
important type of interaction:
(2.3)
Since number of atoms per unit mass of a material is inversely proportional to its
atomic number, photoelectric mass attenuation coefficient is proportional to:
(2.4)
Therefore, photoelectric absorption is a dominant interaction for photons
used in diagnostic imaging and high atomic number materials. This explains why
high contrast is possible with contrast agents (high Z materials like iodine [Z=53]
and barium [Z=56]) and lower energy photons.25 It also explains why x-ray
detectors and shielding materials are made of high Z elements, such as
gadolinium (Z=64) and lead (Z= 82), respectively.26 In therapy applications the Z 3
dependence leads to significant dose deposition in tissues with high Z such as
bone for superficial energy range 20-150 keV.
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2.1.2 Compton scattering
In Compton scattering, the incident photon interacts with a loosely bound
(nearly free) outer shell electron (of rest mass

) of an atom. The incident

photon transfers some fraction of its energy to the electron ejecting it from the
atom and gets scattered with reduced energy. As shown in Figure 2.2, the
electron is scattered through an angle
scattered through an angle

and the photon is
with respect to the original

direction of the incident photon. Based on the principle of conservation of
momentum and energy, kinematics of Compton interaction can be represented
as:

Figure 2.2: In Compton scattering, the incident photon is scattered by a free
electron at an angle . The Compton electron carries energy T in its direction of
scatter

Energy and momentum are conserved in the interaction. Courtesy of F.

H. Attix.27
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(2.5)

(2.6)

(2.7)

The energy of scattered photon (

) becomes smaller as its scattering

angle increases. The higher the incident photon energy (
of the scattered photon. At very low photon energies (
backscattered whereas at higher photon energies (

), the lower the energy
), photons get
), scattering of

photons is more forward peaked.28,29
The electron-photon interaction in Compton scattering can be fully
explained within the theory of Quantum Electrodynamics. The Klein-Nishina law
gives a differential cross section for photon scattering at a given angle per unit
solid angle and per unit electron using relativistic concepts. The integral of the
differential cross section over all solid angles (i.e. over all possible photon
scattering angles from 0 to 180 degrees) yields the total K-N cross-section per
electron.30
(2.8)

Here,

(2.9)

So the K-N cross section per atom of atomic number Z is:
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(2.10)

Since

is independent of Z, the Compton cross section per atom is proportional

to Z.
i.e.

(2.11)

Therefore, Compton mass attenuation coefficient

is independent of Z.

Since the Compton interaction occurs with free electrons of the medium, the
probability of this interaction is proportional to the electron density. Therefore,
hydrogenous materials have almost twice the probability of Compton scattering
compared to other nonhydrogenous materials. In the diagnostic x-ray energy
range (10-150 keV). Compton scatter probability is independent of energy
whereas at higher energies, it is inversely proportional to energy.31
Compton scattering predominates in soft tissues in the energy spectrum
as low as 26 keV. In the diagnostic energy range used in medical applications,
Compton scattering predominates over photoelectric absorption in most human
tissues.32 Since the randomly scattered photons that reach an image receptor
produce noise to the image, Compton interactions lower the contrast in the
image. The scattered Compton electron is mainly responsible for ionization
events and therefore responsible for biological damage as it traverses through
the matter. The scattered photon on the other hand can interact again with an
orbital electron at another location. The energy deposition pattern is, therefore,
more diffuse.
27

2.1.3 Pair production
Pair production is an interaction between an incident photon and electric
field of a nucleus. In this interaction, the photon loses all of its energy and an
electron

–positron

pair is produced. The threshold energy for pair

production is 1.02 MeV, the rest mass energy equivalent of two electrons. The
kinetic energy shared by a pair is the difference between the incident photon
energy and the threshold energy for pair production.
(2.12)
The nucleus recoils to conserve momentum. The pair has significant range and is
responsible for the ionization, and therefore responsible for the associated
biological damage that occurs. When the positron comes to rest, it annihilates
with another electron in the medium liberating two oppositely directed 0.511 MeV
photons as shown in Figure 2.3.
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Figure 2.3: In pair production, an incident photon vanishes on its interaction with
electric field of nucleus and gives rise to an electron-positron pair. Positron
comes to rest after traversing a short distance in a medium and then annihilates
with electron producing two 0.511 MeV photons. Courtesy of J.T. Bushberg et.
al.33
Pair production cross-section per atom is proportional to:34
(2.13)

So the mass attenuation coefficient for pair production is:
(2.14)

Because of the threshold energy requirement, pair production has no role in
diagnostic x-ray imaging. But at the high energy used in RT, the pair produced in
the interaction has significant range and is responsible for the ionization, and
therefore associated with the biological damage that occurs. The annihilation
photons can undergo other interactions and hence have diffuse pattern of energy
deposition.

2.1.4 Rayleigh scattering
In Rayleigh scattering, the incident x-ray photon interacts with an entire atom.
When the atom‘s electron cloud returns to ground state energy level, a photon of
the equal energy but in a slightly different direction is emitted as shown in Figure
29

2.4. Scattered photons mostly traverse in forward direction, also known as
coherent or elastic scattering.35

Figure 2.4: In the Rayleigh scattering event, the incident photon scatters off the
entire atom. Since the energy of the scattered radiation is the same as the
incident radiation, this is also called coherent scattering. Courtesy from J.T.
Bushberg et. al.36
Rayleigh cross-section per atom is:37

(2.15)

Therefore, the Rayleigh mass attenuation coefficient is:
(2.16)
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The probability of this interaction increases with increasing Z of the
medium and decreasing energy of incident x-ray. This occurs only with very low
energy diagnostic x-rays (e.g. mammography). The probability of this interaction
in soft tissues for diagnostic energy used in medical applications is very low
(

). Since no energy is transferred to the medium, Rayleigh scattering plays

no role in dose deposition.38

2.1.5 Total mass attenuation coefficient
The total mass attenuation coefficient is a linear sum of all contributions from
photoelectric absorption, Compton scattering, pair production and Rayleigh
scattering (neglecting photonuclear interactions), and is given by:39

(2.17)
Figure 2.5 shows photoelectric, Compton, pair production, Rayleigh and
total mass attenuation coefficients for low Z material, soft tissue (effective atomic
number ~7). Photoelectric interaction is dominant only at the low energy
spectrum (<26 keV). It rapidly drops off with an increase in energy. Compton
interaction is dominant throughout most of the energy spectrum in soft tissue.
Only at energy greater than 1.02 MeV, does pair production contribute to
attenuation. Rayleigh contribution to attenuation is very small in the low energy
spectrum.35
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Figure 2.5: Mass attenuation coefficients (Rayleigh, Compton, photoelectric, pair
production and total) for soft tissue as a function of energy. Courtesy of J.T.
Bushberg et. al.40
Figure 2.6 shows the mass attenuation coefficients for lead. Though
Compton interactions also decrease with energy, this effect is more pronounced
with photoelectric interaction. Abrupt increases in attenuation for lead occur at
the L- edge and K-edge absorption discontinuities of 13-16 keV and 88 keV
respectively.41 When the photon energy (88-90 keV) is just above the K shell
binding energy (88 keV), the probability of photoelectric absorption increases for
two reasons. First, a small increment comes from an increase in the number of
electrons (from 80 to 82) available for the interaction. Second, a large increment
comes from a resonance phenomenon that results in a disproportionally large
number of K shell interactions.
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Figure 2.6: Mass attenuation coefficients (Rayleigh, Compton, photoelectric, pair
production and total) for lead as a function of energy. Courtesy of F. H. Attix.42
In the diagnostic energy range, two interactions are responsible for
attenuating the radiation: photoelectric and Compton. Because of the Z 3
dependence, photoelectric absorption can produce better contrast between
tissues with slightly different atomic numbers, such as in the case of
mammography. Photoelectric absorption is dominant when diagnostic energy
photons interact with high Z materials like contrast agents, bone, lead and screen
phosphors. However, in cases of lower atomic number materials like tissue and
air, Compton interactions dominate in diagnostic energy range. At the
intermediate energy range (60 keV - 2 MeV), Compton interaction is the
dominant mode of interaction for all types of materials.
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2.2

Working Principle of Indirect Type FPD
FPD consists of a two dimensional array of millions of independent, pixel-

size amorphous silicon (aSi) photodiodes and thin-film transistors (TFTs)
deposited on a single glass substrate. aSi photodiodes are ‗n-i-p‘ types such that
the bottom layer is electron rich, the middle layer is intrinsic and the top layer is
hole rich.43 Each TFT acts essentially as a switch to access the associated
photodiode making up an individual detector element. The source terminal of the
TFT is the capacitor that stores the charge accumulated during exposure, the
drain of the TFT is connected to the readout line and the gate terminal is
connected to the horizontal wires called gate lines. The conductive state of the
TFT is controlled through the applied voltage. Negative voltage applied to the
gate causes the switch to be turned off, whereas a positive voltage applied to the
gate causes the switch to turn on.44
Layers of aSi, various metals and insulators are deposited on a single
glass substrate utilizing the thin film technology to form the photodiodes, TFTs
matrix, the interconnections, and the contacts on the edges of panel. Since the
bulk part of FPD consists of aSi TFT arrays, it is also called TFT image
receptors.45
A uniform layer of thallium-doped cesium iodide scintillator is deposited
directly on top of the aSi structure. Since the structured phosphor provides good
absorption efficiency and good resolution, the phosphor is grown in very thin
needles on the array.
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The thallium doped cesium iodide (CsI:Tl) scintillator first absorbs x-ray
photons and converts them into light photons. These photons then channel
toward an array of photodiodes where they are converted into electrons. During
image acquisition, a negative voltage is applied to the gate lines during exposure,
causing all of the transistor switches on the FPD to go to an off state and
allowing charge accumulation.
During readout, switches for all detector elements along a row are turned
on by applying positive voltage to each gate line, one gate line at a time. The
multiplexer sequentially connects each vertical wire to the digitizer by means of
switches. Each detector element along each row 46 is read out (Figure 2.7). Then
the charge from each detector element is digitized by the analog to digital
converter attached to each column, forming a digital image. The FPD only
requires a number of electronic channels equal to the number of columns of the
array.12
Each detector element of the FPD has a light sensitive region (called a
photoconductor), and a small corner of it contains the electronics (e.g., the
switch, capacitor, etc.). The fraction of the light-sensitive area relative to the
entire area of the detector element is called the fill factor. Large detector
elements have a high fill factor resulting in high contrast. Conversely high spatial
resolution can be obtained with small detector elements.47 Because of this, there
is a tradeoff between contrast resolution and spatial resolution in choosing the
detector elements size.
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Figure 2.7: The readout process for a FPD. Blocks A through I each represent a
detector element. Rows R1 through R3 each represent a gate line. Columns C1
through C3 each represent a readout line. The FPD only requires a number of
electronic channels equal to the number of columns of the array. Courtesy of J.T.
Bushberg et. al.48
An aSi ﬂat panel (model PaxScan 4030CB) of the Varian OBI device has
an active rectangular imaging area of 397 mm x 298 mm. The pixel matrix size
can be varied by grouping detector units together. This is called binning. The OBI
system has a flat-panel detector with a matrix dimension of 1024×768 (i.e. 2×2
binning mode) producing 1024×768 resolution images. It has a pixel pitch of 194
µm (i.e. 194 µm per pixel resolution) and a fill factor of 70%.49
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2.3

Risk, Benefit Analysis for X-ray Imaging Procedures
Medical imaging methods can be broadly categorized as either using

ionizing or non-ionizing techniques. Each of the imaging modalities uses different
forms of energy, interacts with different human tissues in different ways and
correspondingly provides different kinds of anatomic and physiologic information
about them. Medical imaging is not only limited to the diagnosis of diseases, it
has evolved into a tool for intra-operative navigation, radiotherapy planning,
tracking of organ motion during radiation delivery, surgical planning, and tracking
the progress of disease.
In the United States, the average American receives the effective doses of
3mSv per year due to exposure to ionizing radiation from different medical
procedures.50 The average effective doses of radiation from select diagnostic
medical procedures are listed in Table 2.1.51

54

Exact doses to individuals may

differ largely from these typical numbers according to the image acquisition
parameters used in imaging modality based on the individual‘s body size and
shape, as well as other factors.
CT involves larger radiation doses than the more common, conventional xray imaging procedures, making CT the largest contributor of medical radiation
exposure to patients in most parts of the world. Although CT accounts for only
11% of all x-ray based examinations in the United States, it contributes 66 % of
the total diagnostic dose delivered to patients.55 Since the use of CT is growing
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exponentially because of its diversity in several applications, imaging dose is also
escalating proportionally.56
Table 2.1: Typical effective doses from various medical imaging procedures.
Diagnostic procedure

Average effective dose in mSv

Chest radiography

0.2

Abdomen radiography

0.7

Pelvic radiography

0.6

Skull radiography

0.1

Mammography

0.4

CT chest

7.0

CT abdomen

8.0

CT pulmonary angiography

15.0

CT pelvis

4.0

CT coronary angiography

16

CT brain

2.0

Lumbar spine radiograph

1.5

Barium enema exam

8.0

Radiation dose presents two potential health hazards: stochastic and
deterministic effects. These radiogenic effects result from direct and indirect
interactions that damage DNA. In a direct interaction, damage occurs when a
photoelectric or Compton electron ionizes a DNA molecule. In an indirect attack,
hydroxyl (OH) free radicals are liberated by ionization of water molecules in the
cells. These radicals may trigger DNA strand breaks or modify purine and
pyrimidine bases of DNA, leading to cell death.57
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Deterministic injury such as skin burns, fibrosis and cataracts occur with
high doses because the radiation kills a large number of cells. These effects
manifest only above a certain threshold dose that depends on the type of
radiation, health state of the individual, tissue type and biological end point. The
severity of damage increases with dose.

Stochastic effects, such as late health hazards like radiation induced
cancer and genetic errors, arise from exposure to low dose radiation. Stochastic
effects have no dose threshold because damage to a few or even a single
somatic or germ cells can produce radiogenic cancer and heritable genetic
errors. While the probability of occurrence of this type of effect is proportional to
dose, its severity is independent of dose.58
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The dose from imaging procedures mainly poses the threat of stochastic
risks. In few instances of prolonged interventional fluoroscopic procedures,
deterministic injury was also observed.61 The International Commission on
Radiological Protection (ICRP) estimates that the probability of induction of a
stochastic radiogenic cancer is 5 % Sv–1, as a rule of thumb.50,62
Infants and children are of greatest concern regarding stochastic risks.
Cells in younger people are rapidly dividing and therefore are more radiosensitive
and less effective at repairing the damage caused by ionizing radiation. Younger
people also have a longer life expectancy and hence, a greater probability of
occurrence of radiogenic cancer. The unfortunate practice of using the same
machine settings for imaging children and adults results in a large dose of
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radiation for children. This is a particularly important concern during CT
scanning.63,64
Similarly, use of diagnostic imaging (particularly of abdomen and pelvis) in
pregnant women is an important issue as it may cause radiation-induced
teratogenic effects on the fetus (e.g. smaller head or brain size, abnormally slow
growth, and mental retardation). Depending on the stage of pregnancy at the
time of irradiation and amount of radiation dose received, the potential risks
include prenatal death, intrauterine growth restriction, small head size, mental
retardation, organ malformation, childhood cancer, and the occurrence of
hereditary effects in the descendants.65
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Therefore, x-ray based medical imaging involves trade-offs between the
benefits of accurate diagnosis and the low-probability of radiation-induced risks.
It should be carried out only when the benefits outweigh the potential risks.
Non-ionizing radiation imaging techniques are the best option for children
and pregnant women as they eliminate the burden of radiation risks. In routine xray imaging, a high contrast image can be created by decreasing kVp applied
across the x-ray tube and increasing mAs for image acquisition which results in
high imaging dose to patients.69
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When imaging with ionizing radiation is

necessary, potential imaging dose risks can be reduced by using less radiation to
create the image which has the contrast just enough for diagnostic purpose.
In x-ray based imaging techniques, the subject contrast among different
objects is due to differential attenuation. The dominant mode of interaction in
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most imaging modalities is Compton scattering (photoelectric is dominant in
mammography), and the attenuation coefficient is higher at low kV energies.72,73
This results in greater contrast among different tissue types at lower kVp
settings.
If a small fraction of photons reach the detector, noise will dominate the
image

and

the

borders

between

different

contrast

regions

become

indistinguishable. Image noise can be decreased by increasing detector signalto-noise ratio (SNR) at higher mAs values for a given kVp.74 But in this case,
dose deposited to the tissues will be high.
Image only has to be clinically adequate to make a reliable diagnosis so
there will be no need for repeated imaging as a result of poor quality image.
Image does not need to be the best quality at the cost of high dose.75 Imaging
dose should be kept as low as possible without losing essential imaging
information, adhering to the principle of ALARA (as low as reasonably
achievable).
The need for CT exams should be scrutinized before the imaging of
children and pregnant women.76
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Standardized optimal operating procedures

should be integrated in different radiological examinations to reduce the imaging
dose and hence the associated risks.79
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IGRT uses kV or MV x-ray imaging modalities as a tool for patient
positioning, target localization and beam placement during external beam
radiation therapy (EBRT). During RT treatment, patients are exposed to very high
41

and localized doses of radiation. Since IGRT procedures add a small imaging
dose to the high therapeutic dose, this imaging dose has been neglected in most
cases. Though small, each IGRT modality contributes dose to the patient which
may be high over the course of fractionated treatment. This imaging dose also
has associated risk, mostly stochastic risks of long-term induction of cancer and
possible hereditary effects.82,83 There is a need to adhere to modern radiation
protection regulations for imaging in radiotherapy such as practicing ALARA. In
imaging procedures for IGRT, the conformal dose delivered to tumor, sparing
surrounding normal tissue, should outweigh the potential stochastic risks.
Increased imaging dose during IGRT significantly improves patient positioning,
target localization and external beam alignment in radiotherapy and hence can
reduce dose to healthy tissue.
An imaging dose in IGRT should be optimized so as to have a low overall
concomitant dose to healthy tissue around the tumor site region and also
minimizing diagnostic dose elsewhere. The AAPM TG 75 explains the
management of imaging dose during image guided radiotherapy. This group
recommends that management of imaging dose during radiotherapy should be
done differently than during routine diagnostic imaging. This report suggests
three steps for this: 1) assessment of total imaging dose to the patient, 2)
reduction of that dose by refining imaging technique and 3) optimization of
imaging regimen with consideration of cost/benefit analysis of imaging versus
therapy dose.1
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2.4

Calculation of Imaging Dose
Measurement of radiation doses to patients is needed for biological risk

assessment. Air kerma is the kinetic energy transferred to the secondary charged
particle (i.e. electrons) liberated by an x-ray beam per unit mass of air. In the
case of diagnostic x-rays, all the energy transferred to kinetic energy of
secondary electrons is absorbed locally since the range of secondary electrons is
very short in diagnostic energy range. Charged particle equilibrium exists with
diagnostic x-ray photons in air and hence air kerma comes out to be equal to
absorbed dose.84 So, planar kV imaging dose is evaluated traditionally as
entrance skin dose.85
MV imaging dose is quantified in absorbed dose, which has units of J/kg
or Gy. As the range of secondary electrons is too large at MV energies, air kerma
and absorbed dose are not the same. So unlike in kilovoltage imaging, air kerma
cannot be considered the indicator of the associated biological risk from
exposure to MV imaging.1
For CT imaging, dose is most often quantified as the CT dose index
(CTDI) (in mGy).86,87 It is computed by the integral of the absorbed dose profile,
D(z), at a position z along the axis of rotation of the scanner, for a single slice,
divided by the total z-direction beam width, N×T (where N is the number of
slices per tube rotation and T is the acquisition slice thickness):88

(2.18)
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In practice, CTDI100 is measured using a 100 mm long pencil ionization chamber
and it represents the accumulated dose at the center of a single slice of an axial
scan over a profile length of 100 mm.89

(2.19)

In general, CTDI measurements are made by inserting the CT ionization
chamber at the center and at eight equally spaced peripheral positions of a
cylindrical acrylic phantom. CTDI w, the weighted average of these CTDI100
measurements represents the average radiation dose to the patient.
(2.20)
For helical scans at a pitch p, ―volume CTDI‖ is introduced as a correction of the
CTDIw due to the overlap or gap between scans as determined by the pitch.90
(2.21)
Dose length product (DLP) represents integrated dose.91
(2.22)
where L is total z-direction length of the examination.
If deterministic detriments are likely, as reported in the literature from
prolonged fluoroscopically guided interventional procedures, the risk is evaluated
at the entrance using units of Gy.92,93 On the other hand, effective dose is the
standard dose descriptor of the stochastic radiation risk for the induction of
cancer and the induction of genetic effects in the offspring of individuals exposed
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to ionizing radiation. Effective dose (E) is used as a metric for comparison of the
stochastic detriment associated with different diagnostic radiologic procedures.94
Effective dose as defined by Jacobi95 is ―the mean absorbed dose from a uniform
whole body irradiation that results in the same total radiation detriment as from
the non-uniform, partial-body irradiation in question‖.
ICRP- 60 defines effective dose (E) as:96
(2.23)
where the

are the average doses to tissue T for a particular exam, and the

are tissue weighting factors that represent the relative radiation sensitivities of
that tissue. So, effective dose is the weighted summation of the absorbed dose to
each specified tissue multiplied by the ICRP- defined tissue-weighting factor for
that tissue. Stochastic risk is expressed in Sieverts (Sv). The ICRP- 60
probability coefficient of fatal cancer risk is 5.0×10 −2 Sv−1. This coefficient is
based on the linear no- threshold (LNT) model of radiation risk and is derived
primarily from studies of Japanese atomic bomb survivors.97
Measurement or calculation of effective dose is generally very difficult
because the determination of the radiation dose to the body organs is very
difficult, and direct measurement is not possible. So, effective dose from a
particular imaging procedure is obtained by multiplying measurable dosimetric
quantities by a Monte Carlo derived semi empirical conversion coefficient, k.
Measurable dosimetric quantities include air kerma, ESE, dose area product
(DAP) of entrance skin dose, absorbed dose, CTDIair or DLP. For example:
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(2.24)
in radiographic planar imaging98 and
(2.25)
in CT imaging.99,100 The conversion coefficients have been calculated for most
imaging modalities.
A traditional dosimetric quantity called ESE is proportional to absorbed dose
and hence the effective dose. Since it is easy to measure, it is frequently used in
comparing techniques for various radiologic procedures. It is a measure of
exposure in units of Roentgen (R) or milli Roentgen (mR) at the skin surface
where radiation enters the body.101,102 We are going to use ESE in assessing the
dose reduction capability of IPS.
Though the thermo luminescence dosimeter (TLD) placed on the skin of
the patient can directly measure the ESE,103,104 it is not in common use as it
requires a lengthy time for annealing and reading process. Another indirect
method of determining the ESE consists of measurements of DAP using a large
area transmission full-field ionization chamber placed in the beam between the
final collimators of the x-ray tube system and the patient.105,106 But it then
requires a conversion factor to determine the entrance skin dose or exposure.
Measurement of DAP is not feasible in our clinic with the Varian OBI imager
system.
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2.5

Mutual Information
In image analysis, mutual information (MI) serves as an image similarity

metric to evaluate quantitatively the similarity between two images. The concept
of MI comes from information theory.107,108 The MI (A,B), between two images A
and B, can be determined from the entropy of the individual images H (A) and H
(B) and their joint entropy H (A,B).109
(2.26)
Thus, the MI index represents how much uncertainty about one image is reduced
by the knowledge of the second image. It can be considered as a measure of
how well one image explains a second image.108 If A and B are independent,
then A contains no information about B and their MI is therefore zero. If A and B
are identical, their MI is maximized. MI measurements consider the intensity
distribution of both image data sets. All three terms in equation (2.26) rely only on
the probability of occurrence of the various intensities, independent of their
spatial distribution.110
The information available in an image can be measured by its entropy.
The entropy represents the amount of uncertainty, surprise or information gained
from a measurement that specifies one particular value.111 Suppose image A is
represented by a set of intensity values a1, a2,……. an and B is represented by a
set of intensity values b1, b2, …. bn. Let p(a1), p(a2), ………p(an) be the
probabilities for measurements performed on A
a2,……. an. Similarly, let p(b1), p(b2),…….. p(bn)
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yielding the

intensities a 1,

be the probabilities for

measurements performed on B

yielding the

intensities b 1, b2, …. bn. The

Shannon-Wiener entropy measure H is the most commonly used measure of
information in signal and image processing. It involves only the distribution of
probabilities. Then entropies of A and B are given by:109,112
(2.27)
(2.28)
Entropy of the image is calculated from the image intensity histogram in
which the probabilities are the histogram entries.108 An image consisting of
almost a single intensity will have low entropy, whereas the image with roughly
equal quantities of different gray scales will have high entropy.
The joint entropy H (A, B) can be calculated using the joint histogram of
two images. Each point and its associated intensity in one image will correspond
to a point and its respective intensity in the other. Joint intensity histogram is a
two-dimensional scatter plot of image intensity of one image against the
corresponding image intensity of the other. A joint intensity histogram can be
constructed for a pair of images to estimate the probability of occurrence of each
intensity pair together at corresponding locations in the two images. The joint
entropy is defined as:113,109,114

48

(2.29)
where p(ai, bi) is the joint probability which represents probability of cooccurrence of ai, and bi. Therefore, joint entropy measures the amount of
information we have in the two images combined. 111,113,115
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CHAPTER 3: FEASIBILITY OF AN IMAGE PLANNING SYSTEM FOR IMAGEGUIDED RADIATION THERAPY

3.1

Introduction
Image guidance has become the standard of care for many treatment

scenarios in RT. This is most typically accomplished by use of kV x-ray devices
mounted onto the Linac gantry that yield planar, fluoroscopic, and CBCT images.
However, image acquisition parameters are chosen via preset techniques that
rely on broad categorizations in patient anatomy and imaging goal.
In current practice, the addition of imaging and therapy doses in a
meaningful way is suspect. Our project will allow for the addition of these doses,
and therefore enable the clinical and scientific evaluation of the associated
radiation risks. Dynamic target tracking requires that imaging be performed in
real time, and extend for the duration of the radiation delivery. This scenario
would benefit from the ability to prospectively calculate and optimize imaging
dose. Further, the routine practice of RT planning involves the simulation of
radiation beam geometry, and the calculation and review of spatially and
dosimetrically accurate doses. The evolution of this practice into imaging dose is
technologically and procedurally feasible.
One may consider that the dependence of image quality on patient dose
behaves in a manner that is illustrated in Figure 3.1. The image quality, for
example contrast-to-noise ratio (CNR), increases with increasing patient dose up
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to a point. Above the point of object detectability, additional patient dose does not
result in significant or useful improvements in image quality. And for even higher
doses, the detector reaches saturation and image quality degrades. Also
illustrated is an indication of the minimum image quality required to detect a
feature of interest. The optimal imaging technique results in detectability of the
features of interest while exposing the patient to minimum dose. Figure 3.1 also

Image quality

Optimal image acquisition
parameters and patient
dose

Excessive patient dose
relative to the imaging
goal

Minimum image quality
required for reliable object
detection:
i.e., imaging goal

Potentially visible feature
not detactable

Patient dose

Figure 3.1: The quality of an image is a function of the imaging dose received by
the patient. The dotted line indicates the minimum image quality required to
detect a given feature of interest. Without overt image planning, it is probable that
most clinical images are acquired using suboptimal techniques. Insufficient
exposure can leave potentially detectable features masked by image noise, while
excessive exposure yields unnecessary patient dose.
illustrates a line below which the image quality is insufficient to detect a
potentially visible feature. The region above this line represents an opportunity
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that exists in RT localization, in that it may be considered acceptable to increase
the imaging dose substantially in order to detect certain anatomic features.
The goals and constraints that are relevant in a radiotherapy context differ
from those in a diagnostic imaging context. Specifically, the availability of the
planning CT scan provides accurate measures of patient size, anatomical detail
and tissue densities. The goal of imaging is to reveal the geometric location of
the target tissue or local surrogates. Because our patient population suffers from
cancer and the accurate localization of target tissues has the potential to improve
outcomes, the risk-benefit optimization is different than in diagnostic imaging
settings, and often higher imaging doses can be justified. These considerations
are summarized in Table 3.1.
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Table 3.1: Differences in the use of imaging procedures in the context of
radiotherapy are compared to those in diagnostic imaging.
Radiotherapy

Diagnostic Imaging

Characteristic Properties

Image
acquisition
parameters

Properties

Image
acquisition
parameters

Regional
Known via
anatomy and planning CT
tissue
scan
densities

Can be
determined
precisely for
every patient

Estimated
from patient
size and
physical
exam

Estimated,
modified via
iteration and
automatic
exposure
controls

Imaging goal

To visualize
the geometric
extent of
known disease
or local
surrogates

Field of view
and required
contrast are
known

Determine
abnormal
pathology or
lack thereof

Wide field of
view and large
dynamic range
required

Dose
constraints

Wide latitude
based on
patient
population and
potential ease
or difficulty of
visualizing
imaging goal

Larger doses Imperative to
can be
reduce dose
justified if
required

Tradeoffs
between dose
and image
quality are
generalized
based on
population
statistics

Herein, we present an investigation into the feasibility of developing an
IPS for radiotherapy. In this first phase, we focus on developing an algorithm that
can predict the absolute values of tissue contrast that will be produced by a
common radiotherapy planar imaging chain. Input parameters include the CT
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data set of the object of interest, as well as simulated planar imaging technique
settings that include kV and mAs. The response of the FPD is characterized and
integrated into the image simulation algorithm.
We chose to focus initially on simple planar imaging as a feasible first
step, and anticipate that further development will enable optimization in
fluoroscopic and CBCT applications. Planar kV imaging is widely used to affect
three-dimensional patient alignment through the acquisition of an orthogonal pair
immediately prior to treatment. The daily kV planar images are compared to
DRRs that are produced by the treatment planning system or CT simulator
software.
DRRs are constructed by performing a divergent ray trace through the CT
data set, with the source of the trace coincident with the x-ray source and the
image plane coincident with a defined plane, typically either the plane of
isocenter or the imaging detector. Attenuation through the patient or object of
interest is calculated for each ray trace and the resulting transmitted intensity is
mapped to a grey scale value. Voxel-specific attenuation can be calculated
knowing the CT-derived attenuation coefficient and a CT-to-electron density
conversion table that is experimentally measured. The image simulation
algorithm that we are developing is similar to a basic DRR reconstruction, but
differs in several keys aspects. Specifically, it is designed to simulate the
response of the imaging receptor, and incorporates the beam quality and
intensity as input.
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Existing commercial DRR algorithms have user-selectable reconstruction
options such as soft tissue or boney anatomy windows, and depth-of-field
selection116

118

However, the purpose of the DRR is to provide a benchmark

against which daily planar images can be compared. The powerful, but arbitrary
reconstruction tools associated with commercial DRR algorithms do not assist in
the prediction of the characteristics of the daily set-up images, and therefore may
reveal or mask image detail in a different manner than is present in the daily set
up images. Because the goal of daily imaging is to yield consistent and
reproducible patient alignment, it is logical to endeavor for accurate image
prediction rather than reconstruction of imaging detail a goal which would not
exist in the daily set up images. We also note that not all imaging goals are
achievable, especially using simple planar imaging techniques. Our image
prediction system will aid in determining which goals are achievable (e.g., boney
structure or soft tissue contrast for lung nodules) versus those that are
unachievable (e.g., soft tissue contrast in the abdomen or pelvis).
The motivation for this work acknowledges the long experience with
radiological technique charts and automated exposure control (AEC) systems. 119
These techniques are valuable tools with which reasonable acquisition settings
and exposure levels at the detector can be assured. However, they rely on broad
generalizations in patient size and tissue densities. AEC systems result in
consistent image panel exposure, but are not able to modify the prescribed
exposure level when the patient-specific imaging goal warrants increases or
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reductions in exposure, or to selectively optimize based on a specific area of
interest. Low exposure prescans are used in digital mammography to inform the
exposure optimization procedure.120

122

This is similar to the approach we

describe herein, except that the simulation CT scan acts as the prescan,
providing prior knowledge of the subject contrast.
Radiation transport in patient anatomy and imaging detector panels is
most accurately modeled using Monte Carlo methods. These techniques have
most commonly been used to calculate patient dose, most often in CT
applications.123
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In addition, the response of FPDs has been studied using

Monte Carlo techniques.
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While these techniques could be applied to our

application, they are cumbersome to use and require excessive computation time
that undermines their practicality in a clinical setting. As such, we developed an
analytical algorithm to calculate the predicted image parameters.

3.2

Methods and Materials
The algorithm, written in Matlab (The Mathworks, Natick, MA), performs a

divergent ray-trace through a 3D CT data set and impinges on a flat imaging
receptor. Energy-specific attenuation through each voxel of the CT data set is
calculated to derive a net transmitted intensity. In this process, the CT number for
a given voxel is converted to electron density, and the energy-specific
attenuation coefficient for water is found via a lookup table. In this feasibility
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study, the variation in atomic number is not overtly taken into account. We justify
this simplification based on the fact that Compton processes dominate the
interactions at the energies of interest (i.e., 70-150 kVp) and that atomic number
information is not presently attainable in the CT simulator used in this study nor
in most commercial systems of which we are aware. The detector response as a
function of beam quality and exposure was measured and integrated into the
algorithm. It is primarily this latter feature that distinguishes the IPS from a
traditional DRR.
We conducted experiments designed to quantitatively assess the
predictive accuracy of the planning algorithm. These primarily included
assessments of soft tissue contrast resolution in phantoms. Specifically, the
contrast and geometric appearance of a tissue-equivalent lung nodule embedded
in a lung phantom was compared between the IPS and measurements. Small
differences in soft tissue contrast were verified using a mammography step
wedge QA device. Contrast between boney anatomy and soft tissue was verified
using two multimodality imaging phantoms.
A Quasar Programmable Respiratory Motion Phantom (Modus Medical
Systems, London, Canada) was used to determine object contrast and
detectability of a lung nodule test object. Figure 3.2 shows the experimental
arrangement used to acquire the measured data. Projections of the OBI images
of the phantom were acquired at different technique parameters. Comparisons
between simulated and measured images were made in terms of subject contrast
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and dimension of a lung nodule in these images. For all experiments, a GE
Lightspeed CT simulator was used to acquire the CT datasets used for the image
simulation algorithm.

Figure 3.2: Experimental setup. Respiratory phantom was placed on the Linac
couch and AP projection images were acquired at 80 mAs over a wide range of
exposure.
The mammography step wedge phantom, Model 081 (CIRS Tissue
Simulation and Phantom Technology, Norfolk, VA) was placed on top of water
equivalent slabs that were 19 cm in total thickness. Figure 3.3 shows the
experimental arrangement used to acquire the measured data of the phantom.
The variation in pixel intensity across the step wedge was measured in the
simulated and measured images of the phantom at 80 and 120 kVp.
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Figure 3.3: Experimental setup. Mammography phantom was placed on top of 19
cm of acrylic slab to get the appreciable level of attenuation along different
wedges of the phantom. AP projection images were acquired at 80 and 120 mAs
over a wide range of exposure.
Two abdominal phantoms, the Triple Modality 3D Abdominal Phantom,
Model 057 and the Image-Guided Abdominal Biopsy Phantom, Model 071 (both
from CIRS Tissue Simulation and Phantom Technology, Norfolk, VA), were also
studied to assess the contrast between the vertebral bodies and the adjacent soft
tissue. The composition of these phantoms is designed to mimic x-ray properties
for kV imaging. The boney structures are composed of a calcium-doped epoxy
and have an effective atomic number of 8.9. Figures 3.4 and 3.5 show the
relevant experimental arrangements using these phantoms.
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Figure 3.4: Experimental setup. Abdomen phantom model 057 was placed on the
Linac couch with flat face lying on the couch. AP projection images were
acquired at 80 and 120 mAs over a wide range of exposure.

Figure 3.5: Experimental setup. Abdomen phantom model 071 was placed on the
Linac couch with flat face lying on the couch. AP projection images were
acquired at 80 and 120 mAs over a wide range of exposure.
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Measured data were acquired using a Varian 2100 EX Linac (Varian
Medical Systems, Palo Alto, CA) equipped with the OBI system. The OBI
consists of a kilovoltage x-ray tube and aSi FPD mounted onto the gantry
perpendicular to the treatment beam. The imaging system is capable of
producing planar and cone-beam-CT images, although we focus here on the
properties of the planar imaging system.
The response of the FPD was characterized by measuring the resulting
pixel intensity as a function of unattenuated exposure at the detector surface.
Exposure measurements were made using a calibrated Unfors XI Base Unit and
Unfors XI Probe (RaySafe Xi system, Unfors RaySafe, Inc., Hopkinton, MA).
These measurements were repeated over a range of input intensities (i.e., mAs
values) and for 80 and 120 kVp beam qualities. The source-to-detector distance
was 150 cm. The pixel intensity was measured by importing the images into
Matlab and averaging over the 20 cm x 20 cm field of view. The full dynamic
range at each kVp setting was characterized, and these data were integrated into
the planning algorithm in the form of kVp-specific lookup tables.
Contrast was measured by selecting an 8 x 8 pixel ROI in either the lung
nodule or vertebral body and comparing the average intensity to a similar ROI in
the adjacent soft tissue. This is described in equation (3.1), where IntensityROI
and Intensitybkg are the pixel intensities measured in the region of interest and
background, respectively.
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(3.1)

The uncertainty in the measured contrast was estimated using the
equation:
(3.2)

where

and

represent the standard deviation of

intensity in the ROI and background respectively.

3.3

Results
The response characteristics of the imaging detector are shown in Figure
3.6. As anticipated, pixel intensity increases linearly with exposure prior to
100000
Pixel intensity

10000
at 80 kVp
at 120 kVp

1000
100
10
0.0001

0.01

1
100
Exposure (mR)

10000

Figure 3.6: The response curve of the imaging detector is shown. These data
were integrated into the IPS algorithm to predict absolute values of tissue
contrast.
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reaching saturation. The energy independence of the detector response is
evident in the data. The saturation point of the detector is used in the planning
algorithm to predict degradation in object detectability due to over-exposure.
Optimal acquisition techniques will result in image features with appreciable
contrast at low exposure levels.
We studied a lung nodule test object to assess the planning system‘s
ability to predict object contrast and detectability. Simulated images were
constructed over a range of mAs values for 80kV beam quality. The resulting
contrast was assessed by plotting absolute pixel intensity values across the
region of interest. These data are plotted in Figure 3.7. The simulated data
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Pixel Intensity
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0.04mAs, measured image
0.04 mAs, simulated image

1000

0.04 mAs, measured
image, averaged over 4 rows
4 mAs, measured image

100

4 mAs, simulated image
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500 mAs, measured image
500 mAs, simulated image

1
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Figure 3.7: The absolute values of the pixel intensity across the lung nodule
embedded in lung tissue are shown. The edges of the nodule can be appreciated
in both the simulated and measured images. Noise becomes appreciable at low
mAs levels and begins to obscure the nodule in the measured image.
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agree with measured data in that the slope of pixel intensities appears similar,
and the presence of the nodule is evident. Further, image saturation at high mAs
values is evident in both images. However, there is a systematic offset between
the image pairs, with the absolute value of the pixel intensity being higher in the
simulated images. We believe that this may be a limitation of the mono-energetic
approximation used in this study, although we note that the resulting nodule
visibility is similar in both images. Image noise becomes appreciable at low mAs
levels and begins to obscure the nodule in the measured image. This is not
evident in the simulated images as we have not yet incorporated a noise model
into the algorithm.
The geometric appearance of the spherical lung nodule in the respiratory
phantom is a function of the exposure level and image detector saturation. As
saturation is approached, the peripheral contrast and spatial dimensions of the
nodule vary. To study this, we assessed the vertical dimension of the lung nodule
in the measured and simulated images. Good quantitative agreement is seen in
Figure 3.8 and affirms the algorithm's predictive capabilities. Representative
image pairs are shown in Figure 3.9. The invariance of the contrast with kVp and
mAs prior to saturation is predicted, as well as the gradual loss of object
detectability and dimension as saturation is approached. The saturation mAs
level for the 80 kVp beam is higher than the 120 kVp beam, as would be
expected.
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Figure 3.8: The geometric appearance of the lung nodule in the respiratory
phantom is a function of the exposure level and image detector saturation. The
vertical dimension of the visible nodule is predicted by the IPS. The error bars
indicate the uncertainty in the measurement of the diameter of the lung nodule,
and are based on the lack of discrete contrast levels at the lung nodule
boundary.

Figure 3.9: As the image approaches saturation at high mAs values, the nodule
gradually becomes less visible and its geometric dimensions vary. The top row
compares measured (left) and simulated (right) images acquired at 4mAs and 80
kVp. The bottom row compares measured (left) and simulated (right) images
acquired at 100 mAs.
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The ability of the IPS to predict small changes in soft tissue density was
studied using the mammography step wedge phantom placed on top of 19 cm of
polystyrene. The variation in pixel intensity over the range of steps is compared
between the measured and simulated images in Figure 3.10.

Data were

acquired at beam qualities of 80 and 120 kVp and over exposure values ranging
from 0.04 to 500 mAs. The lower exposure value used was the minimum setting
available on the OBI system, while the maximum setting corresponded to image

Figure 3.10: The variation in image detector response is plotted across the
mammography step wedge. Comparison between simulated and measured
images shows good agreement over a wide range of exposure levels and beam
qualities.
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saturation, i.e., 500 mAs at 80 kVp and 100 mAs at 120 kVp. The data show
good agreement in terms of the absolute value of pixel intensities predicted, as
well as small variations across the step wedge pattern. The saturation pixel
intensity was consistent between the two beam qualities studied. The small but
observable slope in the pixel intensity across the step wedge pattern is observed
to be similar in the measured and simulated images.
In Figure 3.11 we compare the simulated and measured images of the
mammography step wedge phantom. Data were collected for these images at 10
mAs and 80 kVp. Qualitatively, there is good visual agreement between the two
images, both in terms of geometric integrity and contrast predictability.

Figure 3.11: The measured image (left) and simulated image (right) of the
mammography step wedge phantom is shown. Data were acquired at 10 mAs
exposure level and 80 kVp beam quality. There is good geometric and visual
agreement between the two images.
Boney tissue contrast was assessed using the two abdominal phantoms
and contrast assessment using methods described above. Measured and
simulated images were generated over a range of mAs values for 80 and 120
kVp beam qualities. The exposure intensity range was selected to span the
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minimum value selectable up through detector saturation. The data are shown in
Figure 3.12. Measured and calculated values agree in terms of predicting the
mAs value at which detector saturation, and subsequent loss of contrast occurs.
There is a systematic offset between the measured and simulated data that may
be due to our simplifications in the beam quality. The lack of variation in contrast
over mAs values lower than 10 suggests that there is wide latitude for minimizing
patient dose.
The data in Figure 3.12 indicate the potential utility of the IPS. It correctly
predicted that the difference in contrast between the two beam qualities studied
is minimal and likely not clinically significant. IPS predicted the invariant contrast

Figure 3.12: The contrast between the vertebral body and surrounding soft tissue
is shown for the two abdominal phantom models studied. The image simulation
algorithm predicts the input exposure level (i.e., mAs setting) at which image
saturation and subsequent loss of contrast occurs.
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with increasing mAs setting, prior to saturation. In addition, IPS predicted the
mAs setting at which saturation would occur. The images used for this
comparison are shown in Figure 3.13.

Figure 3.13: Measured (left) and simulated (right) images are compared for two
abdominal phantoms. Images presented in the top row are from the 057 phantom
and those in the bottom row are from the 071 phantom. Boxes indicate the
regions of interest used to assess the contrast.

3.4

Discussion
The data presented herein are promising in that they support the ability of

IPS to predict the following image characteristics.
Absolute values of pixel intensities and image contrast
Invariance of image contrast with beam quality (over the range studied)
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Loss of object visibility as saturation or underexposure is approached
This information will enable the planning of image acquisition techniques
that reduce patient dose while maintaining the contrast required to achieve the
imaging goal. This process is illustrated in Figure 3.14. Soft tissue contrast was
modeled using the mammography step wedge phantom placed on top of 19 cm
of polystyrene and a 1 mm fiducial BB was located to the right of the phantom.
Simulated images are shown in the top row and were derived by using the thorax
preset values contained in our clinical system (80 kVp, 10 mAs).

Measured

images are shown in the bottom row. Possible improvements in soft tissue
contrast with changes in kVp were assessed iteratively and an alternate image
acquisition technique is included (120 kVp, 5 mAs). Of note is that there is no
clinically relevant change in the contrast between the ROIs indicated in the figure
between the two kVp settings simulated.
The selection of the imaging goal can then proceed. For example, if a soft
tissue target is desired and the contrast appears sufficient to be clinically reliable
(e.g., contrast between ROI 1 and ROI 3), then this may be selected as the
imaging goal, and the image acquisition parameters can be adjusted to reduce
patient dose as low as reasonable while maintaining contrast. If however, the
desired soft tissue target has insufficient contrast to be considered clinically
reliable, despite optimization of image acquisition parameters (e.g., contrast
between ROI 1 and ROI 2), then this goal may be abandoned. In such a case, an
implanted fiducial marker would be a viable surrogate and appropriate imaging
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goal. The image acquisition parameters would then be optimized to visualize the
fiducial marker, and patient dose reduced such that regional anatomy is rendered
minimally recognizable.
This is illustrated in the right-most image in Figure 3.14, in which the BB
remains clearly visible. Patient entrance exposure for this image is reduced by
approximately a factor of 5, compared to the other two images. Experimental
validation of this process is contained in the bottom row of Figure 3.14, in which
the corresponding images were acquired using our clinical equipment.

Figure 3.14: An example of the use of the IPS in selecting an imaging goal is
shown. Top row: simulated images assessing differences in contrast using
different kVp and mAs settings. Bottom row: measured images. Selection of the
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imaging goal could include soft tissue differentiation, e.g., ROI 3 which is likely to
be reliably visible versus ROI 1 which is not likely to be clinically visible.
Reduction in dose is achieved by declaring the fiducial marker to be the imaging
goal (right column). The low contrast lines are a tennis racquet on the Linac
table.
As a next step, we plan to begin clinical testing and to incorporate a
simple entrance exposure calculation into the algorithm to assist in the planning
and decision process.131

133

Other volumetric dose calculations may be readily

integrated into the algorithm, if deemed advantageous.
The simulated image data presented herein were created using a
computationally efficient monoenergetic beam approximation. Although this is an
oversimplification, we evolved to this method due to its predictive accuracy. As
written, the simulation algorithm is capable of modeling a heterogeneous beam
spectrum. We modeled the beam spectrum using SpekCalc software,134 but this
produced results for which the measured and simulated image data did not
agree. We speculate that this may be due to inaccuracies in the modeled
inherent filtration or other tube characteristics that are difficult to assess
definitively due to vendor proprietary concerns.
The monoenergetic approximation yields functionally sufficient agreement
between measured and simulated data. Notwithstanding, there appears to be a
systematic offset between the simulated and measured images in Figure 3.7 and
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Figure 3.12. We expect that inclusion of an accurate beam heterogeneity model,
coupled with noise and scatter models, will resolve this offset.
The lower limit on the incident exposure level will be dictated by detector
noise and scatter. Although we investigated primitive noise models, we found
their benefit to be limited and did not incorporate them at present. This is due to
the fact that the minimum exposure setting (i.e., mAs setting) generally yielded
images in which the objects of interest were detectable. This is attributable to the
relatively small size (20 cm maximum radiological path length) of the phantoms
studied, and the small variation in their subject contrast. Clinically, the algorithm
will need to properly predict saturation and under-response in the same image.
For example, imaging of the thorax and mediastinum in large patients presents
large variations in subject contrast. Inclusion of noise and scatter models will be
a topic of future studies.
In its present state, the algorithm excludes differences in attenuation
based on atomic number. We believe that this is valid within the context of the
proposed application of the algorithm. The OBI system is most often used
between 80 and 120 kVp. In this energy range, Compton process dominates
which is independent of atomic number of the materials. The effective atomic
number (Zeff) for muscle and bone are 7.3 and 12.3, respectively. Zeff for the
boney structures in the abdominal phantom is 8.9. These differences are
relatively small.
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Further development will include modeling of the atomic number
dependence of the x-ray absorption properties. Extracting this information from
the CT data will require incorporation of novel strategies, but may improve the
predictive accuracy of the algorithm. This would be especially relevant for lower
kVp imaging scenarios in which photoelectric absorption processes begin to
dominate and for very high Z materials such as fiducial markers.
Ongoing work is needed prior to routine clinical implementation. The areas
that we anticipate will require further development and testing include the
following:
Resolution of the most appropriate handling of beam spectrum and
hardening;
Incorporation of noise and scatter models;
Management of atomic number dependencies;
Inclusion of patient dose assessment.

3.5

Conclusions
We developed and tested an algorithm that can be used to assist in kV

imaging technique selection during localization for radiotherapy. The algorithm
uses patient-specific CT data sets and integrates the imaging detector response
to predict absolute values of pixel intensity and image contrast. Phantom testing
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demonstrated the algorithm's predictive accuracy for both low and high contrast
imaging scenarios. Detector saturation with subsequent loss of imaging detail,
both in terms of object size and contrast, were accurately predicted by the
algorithm.

Copyright © Bishnu Bahadur Thapa, 2013
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CHAPTER 4: PROSPECTIVE IMAGE PLANNING IN RADIATION THERAPY
FOR OPTIMIZATION OF IMAGE QUALITY AND REDUCTION OF PATIENT
DOSE

4.1

Introduction
When OBI is used in RT for patient alignment, the region-based contrast

of the anatomic feature of interest is considered to be the imaging goal. 135

137

We

developed and tested the IPS that can be used to assist in planar kV imaging
technique selection during localization for RT (Chapter 3).138 The IPS allows a
user to vary the image acquisition parameters and manually optimize them to
meet the imaging goal at low dose, if possible. Alternatively, the IPS suggests the
techniques that provide increased imaging dose but with improved useful image
quality. As such, the IPS facilitates selection of the image acquisition parameters
using a cost/benefit analysis.
In Chapter 3, phantom testing established the fact that IPS can predict
subject contrast for a range of image acquisition parameters. Results from these
studies also verified that the IPS can assess the underexposure, saturation and a
contrast plateau over a wide range of acquisition parameters. This chapter
includes anthropomorphic phantom data and clinical data to further assess these
IPS‘s capabilities over a wide latitude and its potential for facilitating dose
reduction.
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4.2

Methods and Materials

4.2.1 Image contrast prediction
A female whole-body adult anthropomorphic phantom (model 702-D;
CIRS, Norfolk, VA), was used to test the capability of the IPS in predicting image
contrast over a range of mAs and kVp settings. Images from the head and neck,
thorax and abdomen, and pelvis- were studied separately. The experimental set
up used to generate the AP projection pelvic images is shown in Figure 4.1.
Measured images were acquired at mAs values ranging from 0.02 to 600 at 80
kVp beam quality for three sites. Simulated images of these three sites of the

Figure 4.1: The experimental setup. The phantom was placed on the Linac couch
and measured images were acquired by means of the OBI system attached to
the Linac.
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phantom were generated over the same range of mAs values at 80 kVp using the
IPS. In the case of the pelvis, we also generated simulated and measured
images at 120 kVp beam quality over this range (i.e. from 0.02 to 600) of mAs
values.
Qualitative and quantitative assessments were made of the IPS‘s
capabilities in terms of predicting image contrast, underexposure, saturation and
the image quality plateau. Qualitatively, visual inspection of the image contrast
was compared between measured and simulated images, noting loss of contrast
due to imaging panel saturation or under-exposure. We used MI as a quantitative
similarity metric108,113 to compare measured and simulated images. The
reference image was taken to be the measured image acquired at the lowest
possible mAs value that achieved sufficient contrast necessary for patient
alignment. For example, in case of the pelvic images at 80 kVp, we used the
measured image at 5 mAs as the reference. Table 4.1 lists the acquisition values
for the reference images used in this study. Subsequent images, either
measured or simulated, were produced at different incident exposure (i.e., mAs)
values and compared to the reference image.
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Table 4.1: Image acquisition parameters for reference image of head/neck,
thorax/abdomen and pelvis sites of the anthropomorphic phantom

Site

Reference image acquisition parameters

Head/ Neck

80 kVp, 3 mAs

Thorax/ Abdomen

80 kVp, 3.20 mAs

Pelvis

80 kVp, 5 mAs

Pelvis

120 kVp, 0.5 mAs

For a given beam quality, the MI indices between the reference image and
each of the simulated or measured images were calculated separately for each
site. Figure 4.2 illustrates this process for the pelvic region of the
anthropomorphic phantom with data taken at 80 kVp. The range of simulated or
measured images were compared to the reference image. We expect that if the
IPS accurately predicts the image appearance, that the MI index will be similar at
a given mAs setting for both simulated and measured images, and that the
variation in MI over the tested range will behave similarly.
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Figure 4.2: At 80 kVp beam quality, simulated images were generated over a
range of mAs values and measured image acquired at 5 mAs was taken as the
reference image.

4.2.2

Assessment of dose reduction
We used the image planning algorithm to confirm its use as a tool to affect

imaging dose reduction without loss of useful image contrast. The IPS was used
to suggest acquisition settings for six patients, three of which were treated for
disease in the head and neck, and three for disease in abdominal sites.
Consistent with current clinical practice, we considered the imaging goal
for these patients to be regional boney anatomy. 139,140 Specifically, the cervical
vertebra for the head and neck patients and the thoracic and lumbar vertebra for
abdominal patients were taken as the imaging goal. During image acquisition for
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patient alignment, the vendor-preset values for mAs and kVp were replaced with
values determined through simulations using the IPS. The therapists in our clinic
were asked to assess whether the resulting images were of a similar and useful
quality to the images they typically acquire.
Again, we used the MI index to evaluate the similarity between acquired
images. For all six patients, the reference image was taken to be the image
acquired on the first day of treatment using the manufacturer preset values for
mAs and kVp. For a given patient, the MI index between the reference image and
each of the images acquired on successive treatment days using the same
presets was calculated separately for both AP and lateral projections. This was
done in order to quantify the variability in image contrast using our normal clinical
procedures. This process is illustrated in Figure 4.3.

Figure 4.3: The measured images acquired daily using the preset technique
factors were used to establish normal clinical variability in image quality. A single,
reduced dose image was acquired using technique factors manually derived
using the IPS. The clinical image acquired on the first day of treatment was taken
as reference image for calculation of the MI index.
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Subsequently, we varied the acquisition parameters on one day of
treatment to those suggested using the IPS. The revised parameters were
selected manually to yield similar contrast to the manufacturer preset values, but
to reduce ESE if possible.
ESE was used as a measure of imaging dose. To assess the ESE, we
determined the x-ray tube output. For this, a calibrated Unfors XI Base Unit and
Unfors XI Probe (RaySafe Xi System, Unfors RaySafe, Inc., Hopkinton, MA)
meter was placed on top of the kVD of the OBI system. In our clinic, the
separation between the kVS and kVD is held constant at 150 cm. Exposure
readings were measured as a function of mAs over a range of kVp values.
Figure 4.4 shows the x-ray tube output at 150 cm from the focal spot. The data

Figure 4.4: Varian x-ray tube output measured at 150 cm SSD is shown.
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are consistent with the typical behavior of x-ray tubes in that the output is
proportional to the square of the kVp. Experimental confirmation was deemed
desirable because this data is used for both ESE calculations as well as
calculation of the pixel intensity in the simulation algorithm.
Source to surface distance (SSD) and image acquisition parameters
specific to the patient were used to determine the patient specific ESE, given by
equation 4.1: 141,142

(4.1)

Here, output (mR/mAs) represents the exposure per mAs of the x-ray tube for a
given kVp value and is the mAs value used in image acquisition.

4.3

Results

4.3.1 Image contrast prediction
In Figure 4.5, we present images of the pelvis site of the anthropomorphic
phantom to illustrate the IPS‘s capability regarding predicting image contrast. The
second and third columns compare measured and simulated images at 5 and 10
mAs values at 80 kVp. We see that for both 5 and 10 mAs, corresponding image
pairs have similar levels of contrast. Of note is the observation that the images at
5 mAs have sufficient contrast to meet the imaging goal of boney structure
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visualization. Thus, the IPS not only predicts image contrast, but also predicts
the potential for reducing imaging dose. The left column in Figure 4.5 shows
images acquired at the lower limit of available exposure level (i.e. at 0.1 mAs).
Note the loss of contrast due to under exposure. Similarly, the right column in
Figure 4.5 shows the loss of image contrast due to detector saturation.

Figure 4.5: Pelvic images of anthropomorphic phantom at 80 kVp. These images
illustrate the predictive capabilities of the IPS for subject contrast, under and over
exposure and an image quality plateau for a range of image acquisition
parameters. Images at 5 and 10 mAs values demonstrate the potential for
imaging dose reduction.
In Figure 4.6 we display the behavior of the MI index to assess the
similarity between image pairs over a range of exposure levels using the pelvic
phantom site. The agreement between the data for measured and simulated
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Figure 4.6: Variation of MI for pelvic images of the anthropomorphic phantom at
(a) 80 kVp and (b) 120 kVp beam qualities as a function of mAs demonstrates
the IPS’s predictive capability regarding subject contrast, under and over
exposure and an image quality plateau for a range of image acquisition
parameters. Note that measured images at 5 mAs and 0.5 mAs were taken as
the reference images at 80 and 120 kVp respectively.
image pairs is evident, and supports the assertion that IPS is capable of accurate
image contrast prediction. Further, image contrast degrades at both high and
low limits of exposure and remains relatively constant over a two-decade range
of exposure. This image contrast plateau suggests there is potential clinical utility
of the IPS in reducing patient dose without appreciable loss of image contrast.
Figures 4.7 (a) and 4.7 (b) compare simulated images produced using the
IPS over a range of mAs settings to the reference image for two additional
anatomic sites. Data were produced at 80 kVp beam quality for head/neck and
thorax/abdomen sites of the phantom. These data also show that image contrast
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degrades at both high and low limits of exposure. The image contrast plateaus
for these sites are narrow compared to the pelvis site, although there still
appears to be opportunity for patient dose reduction.

Figure 4.7: Variation of MI as a function of exposure for (a) head/neck site and
(b) thorax/abdomen site of the phantom at 80 kVp beam quality. The contrast
behavior displayed is consistent with similar data collected for the pelvic region.
Note that measured images at 3 mAs and 3.20 mAs were taken as the reference
images for the head/neck and thorax/abdomen sites, respectively.
Data collected using the pelvic region of the phantom are shown in Figure
4.8. It illustrates an important result, in that there is no appreciable improvement
in image contrast resulting from a decrease in the beam quality. That is, the
maximum value of the MI index, or similarity to the optimal contrast image, is not
appreciably different for images acquired at 80 and 120 kVp. Note however that
the data show that the saturation of the 120 kVp images starts at lower mAs
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Figure 4.8: Comparison of the MI index between a measured reference image
and a range of simulated images is shown. The pelvic region of the
anthropomorphic phantom provides the subject contrast and data were
generated at 80 and 120 kVp beam qualities. There is no appreciable increase in
image contrast at 80 kVp over 120 kVp. The IPS predicts the potential for
reducing imaging dose by selecting a high kVp without loss of useful image
contrast. Note that measured images at 5 mAs and 0.5 mAs were taken as the
reference images at 80 and 120 kVp respectively.
settings, as would be expected. These data suggest that the clinical practice of
reducing the kVp in order to improve image contrast should be challenged, at
least in the context of radiotherapy alignment, since use of higher kVp settings
reduces patient imaging dose.

4.3.2 Assessment of dose reduction
The results of our study to verify the potential for imaging dose reduction
are shown in Table 4.2. In all cases studied, we were able to affect a 37% or
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greater reduction in imaging dose to the patient compared to the vendor-provided
preset acquisition parameters.
Table 4.2: Clinical data demonstrates facilitation of imaging dose reduction.
Image acquisition parameters
Patient Site/projection
Head/Neck,
AP
Head/Neck,
Lat
Head/Neck,
AP
Head/Neck,
Lat
Head/Neck,
AP
Head/Neck,
Lat

1

2

3

Abdomen, AP
4
Abdomen, Lat
Abdomen, AP
5
Abdomen, Lat
Abdomen, AP
6
Abdomen, Lat

Entrance skin
exposure (mR)
IPS
Preset
revised

Preset

IPS revised

100 kVp, 8
mAS
70 kVp, 5
mAS
100 kVp, 8
mAS
70 kVp, 5
mAS
100 kVp, 8
mAS
70 kVp, 5
mAS
80 kVp, 32
mAS
85 kVp, 40
mAS
80 kVp, 32
mAS
85 kVp, 40
mAS
80 kVp, 32
mAS
85 kVp, 40
mAS

120 kVp, 2
mAS

94.67

34.73

80 kVp, 1 mAS

29.02

7.68

100 kVp, 5
mAS

103.17

64.48

70 kVp, 1 mAS

30.22

6.04

120 kVp, 3mAS

98.44

44.94

80 kVp, 2 mAS

29.45

15.61

273

170.62

399.19

199.6

270

135.02

424.66

224.28

266.45

196.41

409.28

144.11

80 kVp, 20
mAS
85 kVp, 25
mAS
100 kVp, 10
mAS
100 kVp, 15
mAS
85 kVp, 25
mAS
85 kVp, 25
mAS

We verified both qualitatively and quantitatively that this reduction in dose
occurs with no loss of image contrast. Therapists were asked to evaluate the
contrast of the revised images immediately following acquisition. They found no
significant

difference

between

images acquired
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with

the

reduced-dose

parameters

and

typical

images

acquired

using

the

vendor

presets.

Subsequently, we calculated the MI index as an image similarity metric. Figures
4.9 and 4.10 compare the MI numbers for the images acquired using the
reduced-dose settings to the typical daily images for patient 1 (head/neck site)
and patient 4 (i.e. abdominal site) respectively. The data indicate that the
contrast produced using optimized imaging protocols is comparable to those
typical daily images with preset imaging protocols.

Figure 4.9: The MI index for (a) AP and (b) lateral projections of patient 1(Head/
Neck site) are shown. Histogram data correspond to the range of daily clinical
images acquired using standard preset acquisition parameters. The MI values for
the reduced-dose images are indicated by the red bars and were predicted by
the IPS.
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Figure 4.10: The MI index for (a) AP and (b) lateral projections of patient 4
(abdominal site) are shown. Histogram data correspond to the range of daily
clinical images acquired using standard preset acquisition parameters. The MI
values for the reduced-dose images are indicated by the red bars and were
predicted by the IPS. See Table 4.3 for more information.
Table 4.3 summarizes the results of clinical data presented in Figures 4.9
and 4.10 and includes data for the other patients in our study. The data indicate
that the MI index between the reference image and reduced-dose IPS image is
within one standard deviation of the average MI for the typical daily images.
These data support the assertion that there is no degradation in image contrast
using the reduced-dose acquisition parameters derived using the IPS.
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Table 4.3: MI between reference images versus images with presets and IPS
parameters separately.
MI between reference
image and images with
preset parameters

MI between reference
image and images with
IPS parameters

2.30 ± 0.17

2.25

2.47 ± 0.20

2.23

2.31 ± 0.13

2.41

2.48 ± 0.18

2.43

2.27 ± 0.21

2.33

2.45 ± 0.11

2.47

Abdomen, AP

1.81 ± 0.18

1.84

Abdomen, Lat

1.81 ± 0.15

1.82

Abdomen, AP

1.83 ± 0.14

1.76

Abdomen, Lat

1.80 ± 0.22

1.79

Abdomen, AP

1.86 ± 0.12

1.88

Abdomen, Lat

1.82 ± 0.11

1.74

Patient Site/projection

1

2

3

Head/Neck,
AP
Head/Neck,
Lat
Head/Neck,
AP
Head/Neck,
Lat
Head/Neck,
AP
Head/Neck,
Lat

4

5

6

4.4

Discussion
In its present state, the IPS algorithm calculates differences in attenuation

based on density, but not atomic number. This is valid within the context of the
proposed application of the algorithm. Photoelectric absorption scales as the
cube of the atomic number Z, and inversely as the cube of the energy. Compton
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scattering however is independent of Z and scales inversely with energy. Higher
beam qualities will, therefore, result in less photoelectric and more Compton
attenuation. Linac mounted x-rays systems, such as the one studied here, have a
beam quality range of 40–150 kVp, and are most often used between 80 and 120
kVp. In this range, Compton processes dominate and attenuation coefficients are
independent of atomic number for low and moderate atomic number materials.
Consider that at 80 keV in bone, photoelectric processes account for
approximately 15% of photon absorption, whereas Compton processes account
for 85%.143
Our results illuminate a counter-intuitive trend in which the visible image
contrast appears to be independent of beam quality over the range tested (i.e.,
80-120kVp). Initially, we assumed that by reducing the kVp setting we could
affect an improvement in the contrast of the images, owing to the increase in
photoelectric interactions. We tested this assumption using several phantoms,
including an anthropomorphic phantom that contained human boney anatomy.
Despite aggressively reducing the kVp to the lowest setting clinically available
(i.e., 60kVp) we were not able to produce any improvement in boney or other
tissue contrast that was clinically appreciable. In fact, the image quality was
compromised due to the excessive noise introduced. To resolve this observation,
we present a calculation demonstrating that, in a typical RT clinical scenario,
beam hardening within the patient, and lack of penetration of low kVp spectral
components, renders the low energy photoelectric interactions to be masked.
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Consider the transmission of a hypothetical x-ray beam that has equal
spectral components at 30, 50 and 100 keV. The attenuation through 20 cm of
soft tissue and, separately, 20 cm of soft tissue plus 2 cm of bone are calculated
using the x-ray mass attenuation coefficients for soft tissue and bone provided by
the National Institutes of Standards and Technology (NIST).144 The transmission
through bone is calculated using two methods. The ―full bone‖ method assumes
a density of 1.92 g/cm3 and uses the energy-dependent attenuation coefficients
for bone listed by NIST. The ―water equivalent bone‖ method uses the proper
density of bone (1.92 g/cm3) but uses the energy-dependent attenuation
coefficients corresponding to soft tissue. The former method (full bone) is what
would be expected to be the most accurate taking into account photoelectric
interactions and full Z dependency. The latter method simulates our algorithm,
which accounts for density and energy, but assumes mass attenuation properties
for soft tissue. The contrast is calculated as
Contrast = (A-B)/A

(4.2)

where A is the sum of the net transmission components over all three energies
through 20 cm soft tissue and B is the sum of net transmission components over
all three energies through 20 cm soft tissue plus 2 cm bone.
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Table 4.4: The transmitted intensity is calculated for equally weighted spectral
components of a hypothetical x-ray beam. The “Full bone” calculations consider
photoelectric interactions, whereas the “Water equivalent bone” calculations only
consider Compton processes. The lack of transmission of the 30 and 50 keV
components results in image contrast that is dominated by the 100 keV spectral
component and Compton processes. The two calculation methods yield similar
contrast at the exit of the hypothetical phantom.

The results of this analysis are displayed in Table 4.4. Of note is that the
100 keV spectral component accounts for at least 79 % of the total transmitted
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intensity, whereas the 30 keV component accounts for, at most, 0.5%. (See
‗Fraction of all spectral components‘). The net contrast for the full bone
calculation is 59% and for water equivalent bone is 51%. So, indeed there will be
some improvement in accuracy as we further develop the algorithm. However, in
its current state, the clinically appreciable changes in contrast are driven by and
adequately predicted by the limits of the detector response. This analysis also
supports our observation that the peak kVp value (e.g., 80 kVp) is a good proxy
for a heterogeneous, clinical x-ray beam.
We were very conservative in modifying image parameters in the clinical
study and did not aggressively increase the recommended kVp for the purpose of
reducing imaging dose.
The data presented herein are promising in that they demonstrate the
system‘s ability to predict the following image characteristics:
loss of contrast due to detector underexposure or saturation;
maximum level of image contrast possible for a given imaging goal;
the existence of a contrast plateau, sometimes over a wide latitude;
reduction in imaging dose without appreciable loss of contrast;
inability to improve contrast with changes in beam quality.
The existence of an image contrast plateau with respect to mAs setting
may be intuitive, and we have shown that it can be quantitatively evaluated
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prospectively via the IPS. This information has potential clinical value, in that the
IPS can be used to select the image acquisition parameters that yield visibility of
the objects of interest, or imaging goal, while reducing imaging dose. The data
presented in Figures 4.6 and 4.7 show that the image contrast has a maximum
value, and that this may be characterized as a broad plateau (Figure 4.6) or
gradual peak (Figure 4.7). In both cases, mAs, or imaging dose, may be reduced
such that contrast minimally exceeds that necessary to reveal the imaging goal,
for example, boney anatomy.

This mAs, or imaging dose level, does not

necessarily yield the maximum contrast.
The potential for reducing imaging dose by using this patient-specific
optimization technique is likely understated in the present study.

In testing

imaging parameters derived through use of the IPS, we chose to be very
conservative in changing acquisition techniques from those prescribed by the
vendor preset values. As such, any changes in acquisition parameters were
incremental for this early clinical study, and likely do not exploit further reductions
in dose that may be possible.
Use of the patient-specific CT data set renders the output of the image
planning process to be patient-specific. This study could have a greater clinical
impact in reducing imaging dose when applied to real-time image guidance, in
which multiple frames per second145,146 are acquired for the duration of a
treatment.

In this clinical study, the areas we anticipate will require further

development and testing include:
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resolution of the most appropriate handling of beam spectrum and
hardening;
incorporation of noise and scatter models; and
change of clinical practice to higher kVp setting to see the possibility of
more dose reduction.

4.5

Conclusions
The properties of the IPS algorithm were assessed with anthropomorphic

and clinical data. The data and discussions presented in this chapter further
confirm that image contrast resulting from under exposure, over exposure as well
as a contrast plateau can be predicted by use of a prospective image planning
algorithm. Image acquisition parameters can be predicted that reduce patient
dose without loss of useful contrast.

Copyright © Bishnu Bahadur Thapa, 2013
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CHAPTER 5: CONCLUDING REMARKS

5.1

Summary
Patient alignment is achieved by comparing kV planar images to DRRs

created during the treatment planning process. While the DRRs are to some
degree image simulations, they do not achieve the goal of image optimization or
planning. To our knowledge, there is no commercial DRR reconstruction
algorithm that allows the user to vary the x-ray spectrum (kVp), beam intensity
(mAs) or acknowledges the detector response. In this work, I developed an IPS
that can perform these tasks and hence can be used to assist in kV imaging
technique selection during localization for radiotherapy. The patient-specific CT
scan acquired during routine simulation was used as input. Detector response
was incorporated into the algorithm and simulated images were generated by
mapping the image intensity matrix reaching the detector.
Predictive accuracy of IPS
The predictive capability of the IPS was tested with different phantoms.
 High contrast / boney anatomy
Boney tissue contrast was studied using two abdominal phantoms,
The incident exposure value (i.e., mAs value) for a given kVp at which detector
saturation and subsequent loss of contrast occurs was predicted, as well as the
invariance of the contrast at lower exposure settings.

98

Predictive accuracy was further verified quantitatively using the
head/ neck, thorax/ abdomen and pelvis sites of an anthropomorphic phantom.
MI was used to compare measured and simulated images acquired over a range
of technique settings to a baseline image. The similarity between the MI index for
the measured and simulated images was strong, over the wide latitude of
technique settings tested.
Clinical verification was performed by using the IPS to predict
reduced-dose imaging techniques which were then applied on one day of clinical
image acquisition. Similarity between the revised image and standard images
was established subjectively by human observers, and quantitatively by
calculating the MI index. These methods demonstrated that no clinically
appreciable change in boney anatomy contrast was observed using the revised
acquisition parameters.
 Low contrast / soft tissue visualization
Mapping of the pixel intensity variation across a lung nodule test
object of a respiratory motion phantom demonstrated the loss of contrast at low
and high values of exposure (i.e. kVp and mAs) as well as the invariance of the
contrast with exposure prior to detector saturation.
Similarly, mapping of the pixel intensity variation across a
mammography step wedge phantom demonstrated agreement between
measured and simulated images. Again, saturation, underexposure as well as
small variations in grey scale value were correctly predicted by the IPS.
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 Object detectability and geometric dimensions
Assessment of the lung nodule test object for its detectability, and
geometric dimensions confirmed the IPS‘s ability to predict the loss of
detectability and the reduction in visible dimension of the nodule at low and high
values of exposure.
Dose reduction
 Selection of imaging goal
An anecdotal example supported the viability of using the IPS for
selection of an imaging goal. The mammography step wedge phantom and high
contrast fiducial marker were used to illustrate differences between imaging
goals that are likely achievable or not.
 Reduction in ESE
Prospective selection of image acquisition parameters using the
IPS was verified clinically. The results show that a 37% to 74% reduction in
imaging dose is possible without loss of useful image contrast. This is a
manifestation of the image contrast plateau observed over the course of multiple
experiments contained within this study.
 Use of higher beam quality
Our results illuminated a counter-intuitive trend in which the visible
image contrast appears to be independent of beam quality over the range tested,
(i.e., 80-120kVp). Comparison of the MI index between a measured reference
image and a range of simulated images using the pelvic region of the
anthropomorphic phantom provided the subject contrast for these experiments.
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These data suggest the potential of reducing imaging dose by selecting a high
kVp without loss of useful image contrast.

5.2

Conclusions

Image contrast resulting from under exposure, over exposure as well as a
contrast plateau can be predicted by use of an IPS. Patient specific image
acquisition parameters can be predicted using the IPS that reduce patient dose
without loss of contrast.

Copyright © Bishnu Bahadur Thapa, 2013
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APPENDIX

A. 1

List of Abbreviations

ALARA:

As Low As Reasonably Achievable

AAPM:

American Association of Physicists in Medicine

AEC:

Automatic Exposure Control

aSi:

Amorphous Silicon

BEV:

Beam‘s Eye View

CBCT:

Cone Beam Computed Tomography

CNR:

Contrast to Noise Ratio

CT:

Computed Tomography

CTDI:

CT Dose Index

DAP:

Dose Area Product

DRR:

Digitally Reconstructed Radiograph

EBRT:

External Beam Radiation Therapy

EPID:

Electronic Portal Imaging Device

ESE:

Entrance Skin Exposure

FPD:

Flat Panel Detector

HU:

Hounsfield Units

ICRP:

International Commission on Radiological Protection

IGRT:

Image Guided Radiation Therapy

IMRT:

Intensity Modulated Radiation Therapy
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IPS:

Image Planning System

kVD:

Kilovoltage Detector

kVS:

Kilovoltage Source

Linac:

Linear Accelerator

LNT:

Linear No Threshold

MI:

Mutual Information

MLC:

Multi Leaf Collimator

MV:

Megavoltage

NIST:

National Institutes of Standards and Technology

OAR:

Organ at Risk

OBI:

On Board Imager

QA:

Quality Assurance

ROI:

Region of Interest

RT :

Radiation Therapy

SBRT:

Stereotactic Body Radiation Therapy

SNR:

Signal to Noise ratio

SRS:

Stereotactic Radio Surgery

SSD

Source to Surface Distance

TFT:

Thin Film Transistor

TG:

Task Group

TLD:

Thermo Luminescence Dosimeter

TPS:

Treatment Planning System

VS:

Virtual Simulator
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WW:

Window Width

WL:

Window Length

3-D CRT:

Three Dimensional Conformal Radiation Therapy
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